Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes
about
Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpuraVon Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpuraShear-Induced Unfolding and Enzymatic Cleavage of Full-Length VWF Multimers.Consistency of ADAMTS-13 activity assays: a moderately optimistic view.Deficiency of ADAMTS-13 in thrombotic and thrombocytopenic purpura.Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet.Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.The pathogenicity of von Willebrand factor in thrombotic thrombocytopenic purpura: reconsideration of treatment with cryopoor plasma.A rapid enzyme-linked assay for ADAMTS-13.Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo.ADAMTS13 activity and the presence of acquired inhibitors in human immunodeficiency virus-related thrombotic thrombocytopenic purpura.Advantages and limits of ADAMTS13 testing in thrombotic thrombocytopenic purpura.Novel recombinant glycosylphosphatidylinositol (GPI)-anchored ADAMTS13 and variants for assessment of anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura.STEC-HUS, atypical HUS and TTP are all diseases of complement activation.Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case reportBlood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases.Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients.Molecular challenges and viral diseases.ForumADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis
P2860
Q24620546-97584DB9-6F8C-47DA-B258-1336EFEDF7DDQ24651320-DE2BBF7D-56C3-49AC-9CDD-4A6BE666BF61Q30364288-49066C2A-B398-43C0-B105-1F9A8E043E3EQ33349685-7F48A04D-4247-4A4A-A2AF-F84D22B18F46Q33349696-652E245D-9706-45F9-B63C-D93B5E321F96Q33360049-37D23313-8BAC-48B3-91ED-E0FEA55EFF2AQ33365640-770454F8-8AFC-4431-BFB6-7AA9A1BA9F94Q33369765-B13DECE6-EAA6-49C0-8375-C1E1700C6935Q33369832-19A20D13-B75B-4476-843B-5D1C587AAC3AQ33369893-E01AFB3C-A9CB-47F6-9C49-5B19D44FCF17Q33372115-3DA33DAB-8F25-4075-98C6-6E890637DE5CQ33376401-69ECBB94-AD03-4599-934B-0D9D76A8286EQ33380771-0C166380-66A0-48E5-AE4C-47FC9796DCDBQ33397081-430ABB4D-D45D-4A66-BC22-8C5CCD6DE7FFQ33403359-CFE7F25B-004C-409B-84B7-D4A86EFA775BQ33417655-F9F9AC39-8E24-48AA-BF3E-5FA1FA291073Q36044569-833813ED-0553-49A7-BEA0-2CC804DC107CQ44763754-6B73D153-1099-43D2-B295-9B6A97104105Q45872085-21AF368B-1860-4C86-A226-A14C4264688EQ57703220-6C53F778-97B9-451D-95F6-C875DEF73D6EQ58481440-0B423095-C7DD-4644-B816-03ED6103922D
P2860
Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes
@ast
Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes
@en
Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes
@nl
type
label
Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes
@ast
Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes
@en
Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes
@nl
prefLabel
Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes
@ast
Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes
@en
Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes
@nl
P2860
P1476
Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes
@en
P2093
P2860
P304
P356
10.1046/J.1538-7836.2003.00169.X
P407
P577
2003-04-01T00:00:00Z